Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Other Conditions That May Be A Focus of Clinical Attention
Interventions
DRUG

Metformin

2 doses of Metformin Day 1 1000mg, Day 2 850 mg

Trial Locations (1)

94143

San Francisco General Hospital, San Francsico

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00187681 - Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects | Biotech Hunter | Biotech Hunter